Aspero Medical announces patent award for their micro-texturing Pillar technology designed to improve outcomes of endoscopy procedures
17. August 2021 10:46 ET
|
Innosphere Ventures
Boulder, Colorado, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup company developing new products for the field of gastroenterology, announced that the United States...
Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors
05. April 2021 16:05 ET
|
Metacrine, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
29. Dezember 2020 10:24 ET
|
Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
Aspero Medical receives $225,000 Grant for development of intraoperative gastrointestinal endoscopic balloon overtube
18. August 2020 11:27 ET
|
Innosphere
Boulder, Colorado, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing solutions and applications for the field of gastroenterology, has received a...
Metacrine to Present at Jefferies 2019 London Healthcare Conference
18. November 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Aspero Medical announces James Willett as CEO
19. September 2019 17:26 ET
|
Innosphere
Boulder, Colorado, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Aspero Medical, University of Colorado Boulder spinoff and Innosphere client company, announced today that James Willett has been appointed...
Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures
18. September 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Aspero Medical Receives Seed Round Investment from Innosphere Fund
04. September 2019 15:36 ET
|
Innosphere Fund
Colorado, Sept. 04, 2019 (GLOBE NEWSWIRE) -- The Innosphere Fund, a seed-stage venture fund that was formed to accelerate the growth and exit of Innosphere client companies, announced their second...
Metacrine Doses First Patient in 12-Week NASH Proof-of-Concept Trial with a Sustained FXR Agonist
09. Juli 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, July 09, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine Reports Positive Interim Results with Sustained FXR Agonist in NASH Patients
29. Mai 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...